NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.69
Delayed Data
As of Mar 31
 -0.016 / -2.27%
Today’s Change
0.42
Today|||52-Week Range
1.30
+9.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues11.0M6.9M3.5M684.0K
 
 
 
 
 
Cost of Goods Sold--0.00162.0K486.0K
 
 
 
Depreciation And Amortization425.0K341.0K314.0K--
 
 
 
 
 
Operating ExpensesGross Income--6.6M3.0M198.0K
 
 
 
 
General Expenses14.9M14.9M18.5M17.4M
 
 
 
 
 
Research And Development9.9M9.3M12.5M9.5M
 
 
 
 
 
Total Operating Expenses15.3M15.3M19.0M17.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-8.3M-15.5M-17.2M
 
 
 
 
 
Extraordinary Credit0.001.4M--1.7M
 
 
 
Extraordinary Charge-732.0K0.00-555.0K--
 
 
 
Other Expenses-30.0K-155.0K1.0K392.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-7.0M-16.0M-15.2M
 
 
 
 
 
Income Taxes-2.0K-2.0K-2.0K-2.0K
 
 
 
 
 
Net Income-5.1M-7.0M-16.0M-15.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.8M29.4M38.2M49.6M
 
 
 
 
 
Shares To Calculate EPS Diluted25.8M29.4M38.2M49.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.24-$0.42-$0.31
 
 
 
 
 
EPS Diluted-$0.20-$0.24-$0.42-$0.31
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account